Business Description
OptiNose Inc
NAICS : 325412
SIC : 2834
Description
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.72 | |||||
| Equity-to-Asset | -0.33 | |||||
| Debt-to-Equity | -2.94 | |||||
| Debt-to-EBITDA | -6.13 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.48 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -14.6 | |||||
| 3-Year EBITDA Growth Rate | 57.2 | |||||
| 3-Year EPS without NRI Growth Rate | 44.3 | |||||
| 3-Year FCF Growth Rate | 53 | |||||
| Future 3-5Y Total Revenue Growth Rate | 34.94 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.05 | |||||
| 9-Day RSI | 38.21 | |||||
| 14-Day RSI | 39.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.94 | |||||
| Quick Ratio | 3.59 | |||||
| Cash Ratio | 2.79 | |||||
| Days Inventory | 439.36 | |||||
| Days Sales Outstanding | 95.77 | |||||
| Days Payable | 183.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.5 | |||||
| Shareholder Yield % | 0.49 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.92 | |||||
| Operating Margin % | -25.09 | |||||
| Net Margin % | -54.5 | |||||
| FCF Margin % | -47.04 | |||||
| ROA % | -38.54 | |||||
| ROIC % | -18.88 | |||||
| ROC (Joel Greenblatt) % | -1088.83 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.49 | |||||
| EV-to-EBIT | -8.33 | |||||
| EV-to-EBITDA | -8.48 | |||||
| EV-to-Revenue | 2.32 | |||||
| EV-to-Forward-Revenue | 1.99 | |||||
| EV-to-FCF | -4.95 | |||||
| Earnings Yield (Greenblatt) % | -12 | |||||
| FCF Yield % | -25.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OptiNose Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 69.515 | ||
| EPS (TTM) (€) | -0.333 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 39.29 | ||
| 14-Day ATR (€) | 0.03221 | ||
| 20-Day SMA (€) | 0.87975 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.755 - 1.9 | ||
| Shares Outstanding (Mil) | 150.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OptiNose Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OptiNose Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
OptiNose Inc Frequently Asked Questions
What is OptiNose Inc(STU:0OP)'s stock price today?
The current price of STU:0OP is €0.83. The 52 week high of STU:0OP is €1.90 and 52 week low is €0.76.
When is next earnings date of OptiNose Inc(STU:0OP)?
The next earnings date of OptiNose Inc(STU:0OP) is 2024-11-08 Est..
Does OptiNose Inc(STU:0OP) pay dividends? If so, how much?
OptiNose Inc(STU:0OP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers